Anzeige
Mehr »
Dienstag, 22.09.2026 - Börsentäglich über 12.000 News
Der Markt ist gerade aufgewacht: Atlantico Energy Metals steigt um 100 %
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
QL

WKN: A3C6TD | ISIN: SE0016829824 | Ticker-Symbol: 5QO
Frankfurt
22.09.26 | 09:55
0,032 Euro
0,00 % 0,000
Branche
Software
Aktienmarkt
Sonstige
1-Jahres-Chart
QLUCORE AB Chart 1 Jahr
5-Tage-Chart
QLUCORE AB 5-Tage-Chart

Aktuelle News zur QLUCORE Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
09.09.Qlucore AB: Bulletin from the annual general meeting of Qlucore AB (publ)282The annual general meeting in Qlucore AB (publ) was held today, September 9, 2026, whereby the shareholders made the following decisions. Approval of the income statement and balance sheetThe annual...
► Artikel lesen
09.09.Qlucore AB: Interim report 1 May - 31 July 2026182New product launched: advanced bioinformatics as a cloud service Qlucore faces a significant growth opportunity within its established customer base of world-leading pharmaceutical companies and cancer...
► Artikel lesen
26.08.Qlucore AB: Qlucore Signs Agreement with BioTuring Inc238Nasdaq First North-listed Qlucore, a leading provider of software for data analysis and precision diagnostics, today announced that it has entered into a reseller agreement with BioTuring, a pioneering...
► Artikel lesen
17.06.Qlucore AB: Qlucore Receives Approval for EUR 0.5 Million EU Payment1.031Qlucore, a leading provider of software for precision cancer diagnostics, has received approval for a third payment of approximately EUR 0.5 million under its previously awarded EU grant. The total...
► Artikel lesen
28.05.Qlucore AB: Year-end-report 1 May 2025 - 30 April 2026190AI-based tests for Acute Myeloid Leukemia and Bladder Cancer launched Fourth quarter, 1 February - 30 April 2026Net sales amounted to SEK 1,944k (3,461k).EBITDA adjusted amounted to SEK -2,516k (-2...
► Artikel lesen
13.04.Qlucore AB: Qlucore Launches AI-based test for Acute Myeloid Leukemia176Qlucore, listed on Nasdaq First North, announces the launch of a new Qlucore Insights test (Research Use Only) specifically developed for Acute Myeloid Leukemia (AML). The software-based test delivers...
► Artikel lesen
26.02.Qlucore AB: Interim report 1 May 2025 - 31 January 2026213New product release for protein data analysis launched Third quarter, 1 November 2025 - 31 January 2026Net sales amounted to SEK 2,190k (3,217k).EBITDA adjusted amounted to SEK -3,088k (-5,313k).Net...
► Artikel lesen
QLUCORE Aktie jetzt für 0€ handeln
27.11.25Qlucore AB: Interim report 1 May - 31 October 2025305New share issue fully subscribed, reduced burn rate and additional customer buys Qlucore Diagnostics Second quarter, 1 August - 31 October 2025Net sales amounted to SEK 1,792k (1,855k).Operating result...
► Artikel lesen
27.11.25Qlucore AB: Disposal of intangible assets300Qlucore AB has decided to dispose of certain intangible assets of approximately SEK 19.5 million. The Board of Directors of Qlucore AB (publ) has, for precautionary reasons, decided to dispose of a...
► Artikel lesen
28.10.25Qlucore AB: Qlucore terminates liquidity guarantee agreement278Qlucore AB ("Qlucore") hereby announces that the company has terminated the agreement with Lago Kapital Oy regarding the assignment as liquidity guarantor. The purpose of the liquidity guarantor has...
► Artikel lesen
23.10.25Qlucore AB: Bulletin from the annual general meeting of Qlucore AB (publ)448The annual general meeting in Qlucore AB (publ) was held today, October 23, 2025, whereby the shareholders made the following decisions. Approval of the income statement and balance sheetThe annual...
► Artikel lesen
24.09.25Qlucore AB: Interim report 1 May - 31 July 2025251Funding secured First quarter, 1 May - 31 July 2025Net sales amounted to SEK 811k (1,675k).Operating result (EBIT) amounted to SEK -6,552 (-7,620k).Net result for the period amounted to SEK -6,619k...
► Artikel lesen
12 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1